Heron Therapeutics (HRTX) vs Lifevantage (LFVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lifevantage (LFVN) has outperformed Heron Therapeutics (HRTX) over the past year, losing 35.1% versus a loss of 70.9%. Over five years, LFVN leads with a -12.0% price change compared with -96.4% for HRTX. Lifevantage is the larger company by market cap ($75.4 million vs $70.7 million), about 1.1 times the size.
Lifevantage pays a dividend yielding 3.09%, while Heron Therapeutics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HRTX | LFVN |
|---|---|---|
| Share price | $0.3723 | $5.99 |
| Market cap | $70.68M | $75.41M |
| 1-day change | -3.12% | -0.17% |
| YTD return | -70.44% | -2.60% |
| 1-year return | -70.89% | -35.14% |
| 5-year return | -96.37% | -12.02% |
| P/E ratio (TTM) | — | 14.97 |
| Forward P/E | — | 15.49 |
| EPS (TTM) | $-0.18 | $0.40 |
| Dividend yield | 0.00% | 3.09% |
| Annual dividend | $0.00 | $0.185 |
| 52-week high | $1.58 | $11.71 |
| 52-week low | $0.26 | $3.90 |
| Distance from 52-week high | -76.44% | -48.85% |
| Average volume | 2.58M | 61.18K |
| Shares outstanding | 189.85M | 12.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFVN has outperformed HRTX by 35.8 percentage points over the past year.
- Lifevantage offers a meaningfully higher dividend yield (3.09% vs 0.00%).
HRTX vs LFVN FAQ
Which is bigger, Heron Therapeutics or Lifevantage?
Lifevantage (LFVN) is larger, with a market capitalization of $75.41M compared with $70.68M for Heron Therapeutics (HRTX).
Which stock has performed better over the past year, HRTX or LFVN?
LFVN returned -35.14% over the past 12 months, compared with -70.89% for HRTX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Heron Therapeutics or Lifevantage?
Lifevantage pays a dividend yielding 3.09%, while Heron Therapeutics does not currently pay a regular dividend.
Are Heron Therapeutics and Lifevantage in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.